Shaping Motor Neural Functioning of Developmental Stuttering to Improve Fluency
The Treatment of Persistent Developmental Stuttering: Shaping of Motor Neural Functioning to Improve Fluency
1 other identifier
interventional
24
1 country
1
Brief Summary
Developmental stuttering (DS) is a motor/speech disorder, characterized by specific alterations in the functioning of brain circuits. Non-invasive brain stimulation may be useful to shape the altered functioning and connectivity of these systems. As a consequence, this project aims to expand the neurophysiological understanding of DS, evaluating effects of transcranial electrical stimulation (tES) on speech fluency and brain functioning of adults with persistent DS. This project will provide high-impact insights into the functioning of DS neural system, also proposing innovative and/or personalized rehabilitation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 26, 2022
CompletedFirst Posted
Study publicly available on registry
April 1, 2022
CompletedStudy Start
First participant enrolled
April 2, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2024
CompletedOctober 2, 2024
October 1, 2024
2.4 years
February 26, 2022
October 1, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Speech Fluency and Stuttering Severity (change from baseline)
Utilization of (objective) scales to evaluate stuttering severity and speech fluency (Stuttering Severity Instrument \[range 0-56; higher values indicate higher numbers of dysfluencies\])
Evaluated immediately after the end of treatments
TMS-induced (Motor) Evoked Potentials (change from baseline)
Utilization of Transcranial Magnetic Stimulation to evaluate excitability (and reactivity) of motor cortex
Evaluated immediately after the end of treatments
EEG (change from baseline)
Utilization of EEG to evaluate brain functioning and brain connectivity (delta, theta, alpha, beta, and gamma activity)
Evaluated immediately after the end of treatments
Secondary Outcomes (7)
Stuttering Severity (subjective perception) (change from baseline)
Evaluated immediately after the end of treatments
Stuttering Severity (subjective perception) (change from baseline)
Evaluated about 6 weeks after the end of treatments
Speech Fluency and Stuttering Severity (change from baseline)
Evaluated about 6 weeks after the end of treatments
TMS-induced (Motor) Evoked Potentials (change from baseline)
Evaluated about 6 weeks after the end of treatments
EEG (change from baseline)
Evaluated about 6 weeks after the end of treatments
- +2 more secondary outcomes
Study Arms (3)
Transcranial Random Noise Stimulation
EXPERIMENTALTranscranial Random Noise Stimulation (1.5 mA, High Frequency) administered by using surface scalp electrodes (20 minutes, initial part of the session) in correspondence of associative motor regions, during speech therapy sessions (45 minutes).
Transcranial Direct Current Stimulation
EXPERIMENTALTranscranial Direct Current Stimulation (1.5 mA, anodal) administered by using surface scalp electrodes (20 minutes, initial part of the session) in correspondence of associative motor regions, during speech therapy sessions (45 minutes).
Sham Direct Current/Random Noise Stimulation
SHAM COMPARATORSham stimulation administered by using surface scalp electrodes (20 minutes, initial part of the session) in correspondence of associative motor regions, during speech therapy sessions (45 minutes).
Interventions
transcranial Random Noise Stimulation, transcranial Direct Current Stimulation, or Sham are administered (by means of surface electrodes) on associative motor regions during speech therapy sessions (20 minutes, in the initial part of the sessions; 1.5 mA).
Speech Therapy is associated to transcranial electrical stimulation or sham, during stimulation sessions. Total duration of the single session: 45 minutes
Eligibility Criteria
You may qualify if:
- Right-handed adults with idiopathic, persistent DS since childhood
You may not qualify if:
- Contraindications to non-invasive brain stimulation;
- Currently assumption of drugs acting on the Central Nervous System;
- Presence of overt neurological/psychiatric/medical conditions or overt comorbidities (e.g. obsessive-compulsive disorder).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
IRCCS Ospedale San Camillo
Venice, 30126, Italy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pierpaolo Busan, Dr.
IRCCS Ospedale San Camillo s.r.l.
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Masking Details
- Participants will be randomly assigned to "real" neuromodulation or to "sham" modulation (in addition to speech therapy)
- Purpose
- BASIC SCIENCE
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 26, 2022
First Posted
April 1, 2022
Study Start
April 2, 2022
Primary Completion
August 31, 2024
Study Completion
September 30, 2024
Last Updated
October 2, 2024
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will not share